20 results on '"Gamis, Alan S."'
Search Results
2. Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia
3. Ifosfamide and Vinorelbine Is an Effective Reinduction Regimen in Children With Refractory/Relapsed Hodgkin Lymphoma, AHOD00P1: A Childrenʼs Oncology Group Report
4. A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Childrenʼs Oncology Group
5. AAML0523: A report from the Childrenʼs Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia
6. Acute myeloid leukaemia (AML) with t(6;9)(p23;q34) is associated with poor outcome in childhood AML regardless of FLT3-ITD status: a report from the Childrenʼs Oncology Group
7. BIRC5 (Survivin) Splice Variant Expression Correlates With Refractory Disease and Poor Outcome in Pediatric Acute Myeloid Leukemia: A Report From the Childrenʼs Oncology Group
8. The Prognostic Effect of High Diagnostic WT1 Gene Expression in Pediatric Aml Depends on WT1 SNP Rs16754 Status: Report From The Childrenʼs Oncology Group
9. Outcome of Pediatric Patients With Acute Myeloid Leukemia (AML) and −5/5q− Abnormalities From Five Pediatric AML Treatment Protocols: A Report From the Childrenʼs Oncology Group
10. High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the childrenʼs oncology group
11. Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: A report from the childrenʼs oncology group
12. Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): A report from the Childrenʼs Oncology Group
13. Childrenʼs Oncology Groupʼs 2013 blueprint for research: Acute myeloid leukemia
14. Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder
15. Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Childrenʼs Oncology Group trial A2971: A report from the Childrenʼs Oncology Group
16. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Childrenʼs Oncology Group
17. Respiratory syncytial virus infections in children with acute myeloid leukemia: A report from the Childrenʼs Oncology Group
18. Vitamin supplement use among children with Downʼs syndrome and risk of leukaemia: a Childrenʼs Oncology Group (COG) study
19. Increased Age at Diagnosis Has a Significantly Negative Effect on Outcome in Children With Down Syndrome and Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study 2891
20. Alpha Hemolytic Streptococcal Infection During Intensive Treatment for Acute Myeloid Leukemia: A Report From the Children’s Cancer Group Study CCG-2891
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.